Subscribe To
Acadia pharmaceuticals: what's ahead in 2023
Today, we are circling back on mid-cap biopharma ACADIA pharmaceuticals Inc. for the first time since t...
January 16, 2023, 2:04 pm
Milestone pharmaceuticals (mist) upgraded to buy: here's why
Milestone pharmaceuticals (MIST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimis...
January 16, 2023, 1:33 pm
Flavors for pharmaceutical & healthcare applications market is expected to surpass us$ 1.2 billion in 2023 and is estimated to expand at a cagr of 5.5% from 2023 to 2033| future market insights, inc.
The European healthcare product flavors market is expected to exceed US$ 335 Million by 2033, with a CAGR of 5.2%. From 2023 to 2033, the Asia Pacific...
January 16, 2023, 11:30 am
Are medical stocks lagging acer therapeutics (acer) this year?
Here is how Acer Therapeutics Inc. (ACER) and Syndax pharmaceuticals (SNDX) have performed compared to ...
January 16, 2023, 11:17 am
Acurx pharmaceuticals to present at the emerging growth conference on january 25, 2023
Acurx invites individual and institutional investors, financial advisors and analysts to attend its real-time, interactive question and answer session...
January 16, 2023, 8:01 am
Fennec pharmaceuticals: ruminating the prospects and necessity of a sale
After two rejections, Fennec pharmaceuticals finally secured FDA approval for its only asset, Pedmark.�...
January 16, 2023, 5:45 am
Medivir to present at the redeye fight cancer day
STOCKHOLM , Jan. 16, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical compan...
January 16, 2023, 3:41 am
Syros pharmaceuticals a buy given stock price and pipeline potential (rating upgrade)
Syros pharmaceuticals is developing cancer therapies. Its most advanced potential therapy is tamibarote...
January 15, 2023, 1:52 am
Is it too late to buy vertex pharmaceuticals stock?
Vertex is heading for a new phase of growth....
January 14, 2023, 6:00 am
Kaplan fox reminds investors with losses in spectrum pharmaceuticals, inc. (nasdaqgs: sppi) of february 3, 2023 lead plaintiff deadline
NEW YORK, Jan. 13, 2023 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) filed a proposed class action suit in the United States D...
January 14, 2023, 4:00 am
Opiant pharmaceuticals: nano-cap buyout with interesting cvr thrown in
I love to get a CVR during a takeover process. This happens a lot when pharma or biotech companies with important unapproved assets get bought....
January 13, 2023, 2:26 pm
Pick either merck stock or its peer – both may offer similar returns
We believe that pharmaceutical giants Merck stock (NYSE: MRK) and Pfizer stock (NYSE: PFE) will likely ...
January 13, 2023, 8:00 am
Is spdr s&p pharmaceuticals etf (xph) a strong etf right now?
Smart Beta ETF report for XPH...
January 13, 2023, 7:32 am
Pfizer: recent covid-related headlines call for an updated assessment
The COVID-19 pandemic made Pfizer the most recognizable pharmaceutical company on the planet. But, COVI...
January 13, 2023, 7:30 am
Voyageur pharmaceuticals increases maximum size of its non-brokered private placement to $1.2m due to strong investor demand
Voyageur pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) said it has increased the maximum size of the non-br...
January 13, 2023, 6:48 am
Verona pharma: breathing deeply could bring great benefits
Verona Pharma is a biopharmaceutical company involved in studies and product development related to res...
January 13, 2023, 2:31 am
Puma biotechnology to present at b. riley securities' 3rd annual oncology conference
LOS ANGELES--( BUSINESS WIRE )--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, a...
January 12, 2023, 4:15 pm
Why shares of amryt pharma jumped this week
A takeover bid by an Italian pharmaceutical and healthcare company boosted Amryt's shares....
January 12, 2023, 3:32 pm
Tricida files for chapter 11 bankruptcy protection as it searches for a buyer
Tricida Inc., a clinical-stage pharmaceutical company working on a kidney disease drug, has filed for ...
January 12, 2023, 2:46 pm
Moderna under fire for 400% price hike of covid vaccine: ‘outrageous'
The pharmaceutical giant could raise the price of the vaccine from its current $26 per dose to between ...
January 12, 2023, 12:01 pm